In psoriasis, A3 adenosine receptors represent a new predictive marker as they are known to be overexpressed in the PBMCs of patients with autoimmune inflammatory conditions, e.g., of, RA, and Crohn’s disease. Here, ADORA3 is linked to psoriasis.